1-Ethyl-3-(3'-dimethylaminopropyl)carbodiimide → 1-phenyl-5-trifluoromethyl-1H-pyrazole-4-carboxylic acid {2-[4-(5-fluoro-2-trifluoromethyl-benzoyl)-piperazin-1-yl]-2-oxo-ethyl}-amide

HRID 1177919Notes

Reaction equation

HRID 1177919 reaction equation
CCN(C(C)C)C(C)C.[C:10]1([N:16]2[C:20]([C:21]([F:24])([F:23])[F:22])=[C:19]([C:25]([OH:27])=O)[CH:18]=[N:17]2)[CH:15]=[CH:14][CH:13]=[CH:12][CH:11]=1.C1C=CC2N(O)N=NC=2C=1.CCN=C=NCCCN(C)C.Cl.[NH2:50][CH2:51][C:52]([N:54]1[CH2:59][CH2:58][N:57]([C:60](=[O:72])[C:61]2[CH:66]=[C:65]([F:67])[CH:64]=[CH:63][C:62]=2[C:68]([F:71])([F:70])[F:69])[CH2:56][CH2:55]1)=[O:53]>CN(C=O)C.O>[F:67][C:65]1[CH:64]=[CH:63][C:62]([C:68]([F:70])([F:69])[F:71])=[C:61]([CH:66]=1)[C:60]([N:57]1[CH2:58][CH2:59][N:54]([C:52](=[O:53])[CH2:51][NH:50][C:25]([C:19]2[CH:18]=[N:17][N:16]([C:10]3[CH:11]=[CH:12][CH:13]=[CH:14][CH:15]=3)[C:20]=2[C:21]([F:22])([F:23])[F:24])=[O:27])[CH2:55][CH2:56]1)=[O:72]

Participants

8

Reactant 5

HCID 159081-Ethyl-3-(3'-dimethylaminopropyl)carbodiimideHCID 757711-HydroxybenzotriazoleHCID 81531DiisopropylethylamineHCID 6886991-phenyl-5-(trifluoromethyl)-1H-pyrazole-4-carboxylic acidHCID 669531292-Amino-1-[4-(5-fluoro-2-trifluoromethyl-benzoyl)-piperazin-1-yl]ethanone hydrochloride

Product 1

HCID 251663011-phenyl-5-trifluoromethyl-1H-pyrazole-4-carboxylic acid {2-[4-(5-fluoro-2-trifluoromethyl-benzoyl)-piperazin-1-yl]-2-oxo-ethyl}-amideYield 27.9%

Reagents, catalysts & solvents 2

HCID 962WaterSolventHCID 6228DimethylformamideSolvent

Procedure

DIPEA (141 mg, 0.19 mL, 1.1 mmol) was added to a stirred solution of 1-phenyl-5-trifluoromethyl-1H-pyrazole-4-carboxylic acid (70 mg, 0.27 mmol) in DMF (5 mL). HOBT (40 mg, 0.29 mmol) and EDCI (131 mg, 0.68 mmol) were then added at room temperature. After 2 minutes, 2-amino-1-[4-(5-fluoro-2-trifluoromethyl-benzoyl)-piperazin-1-yl]-ethanone hydrochloride salt (111 mg, 0.3 mmol) was added and the resulting mixture was stirred at room temperature overnight. Cold water was then added and the product was extracted with EtOAc and the organic layer was washed with brine. The organic phase was dried over Na2SO4 and concentrated under reduced pressure to get the residue. The obtained residue was purified by column chromatography (using 60-120 silica gel and 70% EtOAC in hexane as eluent) to afford 43 mg (27.56% yield) of 1-phenyl-5-trifluoromethyl-1H-pyrazole-4-carboxylic acid {2-[4-(5-fluoro-2-trifluoromethyl-benzoyl)-piperazin-1-yl]-2-oxo-ethyl}-amide, LCMS Purity: 86.39%. 1H NMR (CDCl3): δ 8.0 (s, 1H), 7.8 (t, 1H), 7.56-7.4 (m, 5H), 7.26 (s, 1H), 7.1 (d, 2H), 4.36-4.2 (m, 2H), 4.06-3.84 (m, 1H), 3.8-3.64 (m, 2H), 3.62-3.48 (m, 2H), 3.44 (t, 1H), 3.3-3.2 (m, 2H).

Workup

  1. extractionthe product was extracted with EtOAc
  2. washthe organic layer was washed with brine
  3. dry with materialThe organic phase was dried over Na2SO4
  4. concentrationconcentrated under reduced pressure
  5. customto get the residue
  6. customThe obtained residue was purified by column chromatography (using 60-120 silica gel and 70% EtOAC in hexane as eluent)

Sources & evidence

ORD record
ord-260de669955d41b3804bc9e6bf3ec274
Source dataset
uspto-grants-2010_11
Patent number
US07842696B2

Reaction notes

Loading…